MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers

Aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane have shown to prevent metastasis and angiogenesis in estrogen receptor (ER)-positive breast and ovarian tumors. They function primarily by reducing estrogen production in ER-positive post-menopausal breast and ovarian cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales: Barwal, Tushar Singh, Sharma, Uttam, Bazala, Sonali, Singh, Ipsa, Jain, Manju, Prakash, Hridayesh, Shekhar, Shashank, Sandberg, Elise N., Bishayee, Anupam, Jain, Aklank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071157/
https://www.ncbi.nlm.nih.gov/pubmed/33920789
http://dx.doi.org/10.3390/ijms22084072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071157/
https://www.ncbi.nlm.nih.gov/pubmed/33920789
http://dx.doi.org/10.3390/ijms22084072

Ejemplares similares